Edition:
United Kingdom

Oncopeptides AB (ONCO.ST)

ONCO.ST on Stockholm Stock Exchange

82.40SEK
16 Feb 2018
Change (% chg)

1.90kr (+2.36%)
Prev Close
80.50kr
Open
82.50kr
Day's High
83.90kr
Day's Low
79.40kr
Volume
34,092
Avg. Vol
45,075
52-wk High
96.00kr
52-wk Low
41.10kr

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -1.296
Jun '17 0.00 -1.690
Mar '17 0.00 -1.599
FY 2016 Dec '16 0.00 -2.067
Sep '16 0.00 -1.060
Jun '16 0.00 -1.190
Mar '16 0.00 -0.920
 
*Note: Units in Millions ofSwedish Krona
**Note: Units in Swedish Krona

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-18 2 0.00 0.00 0.00 --
Earnings (per share)
Year Ending Dec-18 2 -6.72 -6.21 -7.24 --
Sales and Profit Figures in Swedish Krona (SEK);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 83.93 32.90
P/E High - Last 5 Yrs. -- 292.71 45.97
P/E Low - Last 5 Yrs. -- 91.44 24.37
Beta -- 0.90 0.89
Price to Sales (TTM) -- 110.72 5.77
Price to Book (MRQ) 4.74 13.56 5.41
Price to Tangible Book (MRQ) 4.74 14.02 6.98
Price to Cash Flow (TTM) -- 71.33 23.42
% Owned Institutions -- 12.89 2.22

Dividends

  Company industry sector
Dividend Yield -- 0.31 1.50
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.66 5.21
Payout Ratio(TTM) -- 15.70 43.72

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 398.33 9.24
Sales (TTM) vs TTM 1 Yr. Ago -- 78.63 5.59
Sales - 5 Yr. Growth Rate -- 32.11 10.27
EPS (MRQ) vs Qtr. 1 Yr. Ago -41.99 25.10 19.65
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 38.95 10.73
Capital Spending - 5 Yr. Growth Rate -- 40.24 15.19

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.80 2.18
Current Ratio (MRQ) 9.54 5.30 2.97
LT Debt to Equity (MRQ) 0.00 22.82 12.22
Total Debt to Equity (MRQ) 0.00 24.47 16.52
Interest Coverage (TTM) -- -98.78 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.03 54.70
Gross Margin - 5 Yr. Avg. -- 51.06 52.42
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -572.68 10.86
Operating Margin (TTM) -- -717.10 4.64
Operating Margin - 5 Yr. Avg. -- -594.00 6.26
Pre-Tax Margin (TTM) -- -691.66 5.44
Pre-Tax Margin - 5 Yr. Avg. -- -597.35 6.60
Net Profit Margin (TTM) -- -692.88 1.76
Net Profit Margin - 5 Yr. Avg. -- -600.21 2.91
Effective Tax Rate (TTM) -- 22.57 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.19 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 22,602,121 855,667,832
Net Income/Employee (TTM) -22,784,650 2,968,747 100,655,557
Receivable Turnover (TTM) -- 20.14 5.78
Inventory Turnover (TTM) -- 2.36 3.35
Asset Turnover (TTM) 0.00 0.39 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -66.83 -1.05 10.98
Return on Assets - 5 Yr. Avg. -- -0.57 12.37
Return on Investment (TTM) -76.13 1.66 14.43
Return on Investment - 5 Yr. Avg. -- 2.23 16.18
Return on Equity (TTM) -76.18 2.58 16.13
Return on Equity - 5 Yr. Avg. -- 3.13 17.47
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -114.56 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Oncopeptides AB

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -1.17 -- 73 53
13 Week -1.17 -- 95 62
26 Week 43.67 -- 99 77
52 Week -- -- -- 50
YTD -- -- -- 56
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 84.91%
# of Holders: 19
Total Shares Held: 33,800,197
3 Mo. Net Change: -36,725
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 3
# Reduced Positions: 2
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.